Synaptics faces scrutiny amid ON Semiconductor acquisition
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 27 2025
0mins
Source: Benzinga
Synaptics Inc's stock fell 5.02% as it crossed below the 5-day SMA, reflecting investor concerns following the announcement of its acquisition by ON Semiconductor.
The acquisition, valued at approximately $7 billion, has raised questions about potential fiduciary breaches as investigations by law firms like Ademi LLP are underway. These investigations focus on whether Synaptics' board is adequately protecting shareholder interests amid the deal, which offers shareholders 1.350 shares of ON Semiconductor for each Synaptics share held.
The scrutiny surrounding the acquisition could impact shareholder trust and the overall perception of Synaptics' management, especially as the market reacts to the implications of this significant transaction.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SYNA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SYNA
Wall Street analysts forecast SYNA stock price to fall
11 Analyst Rating
8 Buy
3 Hold
0 Sell
Moderate Buy
Current: 124.210
Low
65.00
Averages
89.22
High
106.00
Current: 124.210
Low
65.00
Averages
89.22
High
106.00
About SYNA
Synaptics Incorporated is a developer and fabless supplier of mixed signal semiconductor solutions that enable people to engage with connected devices and data, and create experiences throughout the home, at work, in the car and on the go. The Company's product categories include core Internet of things (IoT), enterprise and automotive, and mobile. Its core IoT includes products for Wireless and Processor Solutions. Its enterprise and automotive products include products for personal computer (PC) touchpads, PC fingerprints, video interface solutions and automotive solutions. Its Mobile product includes products for touch and display solutions for mobile phone applications. The Company supplies connectivity, sensors and artificial intelligence (AI)-enhanced processor solutions to original equipment manufacturers (OEMs) that design IoT products and devices for automobiles, enterprise workspace devices, virtual reality, smartphones, tablets and notebook computers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating several companies, including Synaptics, Iridium Communications, and Bio-Techne, for potential violations of federal securities laws and breaches of fiduciary duties, which may affect shareholder rights.
- Synaptics Transaction: The deal between Synaptics and onsemi involves exchanging each Synaptics share for 1.350 shares of onsemi common stock, potentially limiting superior competing offers and impacting shareholder options.
- Iridium Transaction: Iridium Communications is selling for $27.00 in cash per share and shares of Rocket Lab common stock calculated via an exchange ratio, prompting shareholders to consider the implications of the transaction terms on their rights.
- Bio-Techne Transaction: Bio-Techne is being sold to Merck KGaA for $73.00 per share in cash, and Halper Sadeh LLC may seek increased compensation and additional disclosures for shareholders regarding the transaction.
See More
ON Semiconductor Acquires Synaptics in $7 Billion Deal
- Acquisition Deal: ON Semiconductor is acquiring Synaptics in an all-stock transaction valued at approximately $7 billion, marking its largest acquisition to date, with Synaptics shareholders receiving 1.350 shares of Onsemi for each Synaptics share, representing a 19% premium based on the 10-day volume-weighted average closing prices.
- Market Expansion: This acquisition is expected to expand ON Semiconductor's addressable market by $30 billion to $243 billion by 2030, highlighting the company's strong growth potential in the physical AI sector.
- Analyst Rating: Cantor Fitzgerald raised ON Semiconductor's price target from $100 to $110 while maintaining a
See More
Mizuho Lowers ON Semiconductor Target, Raises Synaptics Target
- Price Target Adjustments: Mizuho lowered On Semiconductor's price target from $150 to $125 while raising Synaptics' target from $128 to $170, reflecting differing expectations for the future performance of both companies.
- Acquisition Impact: On Semiconductor announced last week its intention to acquire Synaptics in an all-stock deal worth $7 billion, and although this news caused ON's stock to drop approximately 21% post-announcement, analysts view this as a good entry point with expectations for accelerating trends in the second half.
- Market Demand Recovery: Analysts noted that ON is likely to benefit from a recovery in demand for WiFi connectivity, system-on-chip (SoC), and robotics technologies, particularly with AI data center revenues increasing by 100% year-over-year to about $500 million, representing 7% of total revenue.
- Potential Risks: Despite the optimistic outlook for ON, analysts highlighted potential headwinds for Synaptics due to exposure in the PC and consumer electronics markets, especially as Xiaomi has cut its 2026 handset shipment forecast by 30%, which could pose downside risks for SYNA.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating companies such as Iridium Communications Inc., Theravance Biopharma, Inc., Synaptics Incorporated, and Bio-Techne Corporation for potential violations of federal securities laws and breaches of fiduciary duties, which may affect shareholder rights.
- Transaction Details: Iridium Communications Inc. is set to be sold for $27.00 per share in cash and Rocket Lab stock, while Theravance Biopharma, Inc. is priced at $17.00 per share, Synaptics Incorporated at 1.350 shares of onsemi stock per share, and Bio-Techne Corporation at $73.00 per share in cash.
- Shareholder Rights Protection: Halper Sadeh LLC encourages shareholders to contact the firm to discuss their rights and options at no cost, aiming to provide legal support and potential compensation for affected investors.
- Legal Service Commitment: The law firm commits to handling cases on a contingent fee basis, meaning shareholders will not be responsible for upfront legal fees or expenses, ensuring that more investors can access legal assistance.
See More
Chip Stocks Face Sell-Off, Investment Opportunities Emerge
- Market Sell-Off Impact: Chip stocks, particularly Nvidia, ON Semiconductor, and Intel, have faced significant declines this week due to increasing doubts about the returns on AI spending, putting pressure on the entire sector and requiring investors to navigate market volatility cautiously.
- Nvidia's Strong Performance: Despite an 18% drop from its 52-week high, Nvidia reported an 85% year-over-year revenue increase to $81.6 billion in Q1 2027, with data center revenue soaring 92% to $75.2 billion, highlighting its robust position in the AI market.
- ON Semiconductor Acquisition Risks: ON Semiconductor's stock plummeted 23% following its announcement of a $7 billion acquisition of Synaptics, raising concerns about shareholder dilution and integration risks, even as its Q1 revenue grew 5% year-over-year, which may impact its stock performance in the short term.
- Intel's Turnaround Challenges: Intel's stock has rebounded to around $128 from a 52-week low, with Q1 revenue up 7% to $13.6 billion, and securing Tesla as a major customer; however, it still faces profitability issues, making its turnaround uncertain and requiring investor vigilance.
See More
Chip Stocks Volatility and Investment Opportunities
- Nvidia Valuation Drop: Nvidia now trades at about 29 times earnings, significantly below its average over the past year, despite reporting an 85% year-over-year revenue increase to $81.6 billion in Q1 2027, with data center revenue soaring 92% to $75.2 billion, indicating strong performance in AI; however, market doubts about the sustainability of AI spending may lead to further stock volatility.
- ON Semiconductor Acquisition Risks: ON Semiconductor's announcement of a $7 billion all-stock acquisition of Synaptics triggered a more than 23% drop in its stock price in one day, although its Q1 revenue rose 5% year-over-year, signaling a recovery, the dilution effect of the acquisition and integration risks have unsettled investors, necessitating close monitoring of future performance.
- Intel Turnaround Success: Intel's stock has surged from a 52-week low of $19 to over $141, with Q1 revenue increasing 7% to $13.6 billion; however, despite reporting non-GAAP earnings of $0.29, its foundry business still lost $2.4 billion, indicating that the turnaround is not fully realized, and investors should remain cautious.
- Market Sentiment Impact: The entire chip sector has faced sell-offs due to concerns over AI spending, and while Nvidia, ON Semiconductor, and Intel each face unique challenges, this situation presents investors with opportunities to buy quality stocks at discounted prices, particularly as Nvidia maintains a competitive edge in a rapidly growing market.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating several companies, including Synaptics, Iridium Communications, and Bio-Techne, for potential violations of federal securities laws and breaches of fiduciary duties, which may affect shareholder rights.
- Synaptics Transaction: The deal between Synaptics and onsemi involves exchanging each Synaptics share for 1.350 shares of onsemi common stock, potentially limiting superior competing offers and impacting shareholder options.
- Iridium Transaction: Iridium Communications is selling for $27.00 in cash per share and shares of Rocket Lab common stock calculated via an exchange ratio, prompting shareholders to consider the implications of the transaction terms on their rights.
- Bio-Techne Transaction: Bio-Techne is being sold to Merck KGaA for $73.00 per share in cash, and Halper Sadeh LLC may seek increased compensation and additional disclosures for shareholders regarding the transaction.
See More
ON Semiconductor Acquires Synaptics in $7 Billion Deal
- Acquisition Deal: ON Semiconductor is acquiring Synaptics in an all-stock transaction valued at approximately $7 billion, marking its largest acquisition to date, with Synaptics shareholders receiving 1.350 shares of Onsemi for each Synaptics share, representing a 19% premium based on the 10-day volume-weighted average closing prices.
- Market Expansion: This acquisition is expected to expand ON Semiconductor's addressable market by $30 billion to $243 billion by 2030, highlighting the company's strong growth potential in the physical AI sector.
- Analyst Rating: Cantor Fitzgerald raised ON Semiconductor's price target from $100 to $110 while maintaining a
See More
Mizuho Lowers ON Semiconductor Target, Raises Synaptics Target
- Price Target Adjustments: Mizuho lowered On Semiconductor's price target from $150 to $125 while raising Synaptics' target from $128 to $170, reflecting differing expectations for the future performance of both companies.
- Acquisition Impact: On Semiconductor announced last week its intention to acquire Synaptics in an all-stock deal worth $7 billion, and although this news caused ON's stock to drop approximately 21% post-announcement, analysts view this as a good entry point with expectations for accelerating trends in the second half.
- Market Demand Recovery: Analysts noted that ON is likely to benefit from a recovery in demand for WiFi connectivity, system-on-chip (SoC), and robotics technologies, particularly with AI data center revenues increasing by 100% year-over-year to about $500 million, representing 7% of total revenue.
- Potential Risks: Despite the optimistic outlook for ON, analysts highlighted potential headwinds for Synaptics due to exposure in the PC and consumer electronics markets, especially as Xiaomi has cut its 2026 handset shipment forecast by 30%, which could pose downside risks for SYNA.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating companies such as Iridium Communications Inc., Theravance Biopharma, Inc., Synaptics Incorporated, and Bio-Techne Corporation for potential violations of federal securities laws and breaches of fiduciary duties, which may affect shareholder rights.
- Transaction Details: Iridium Communications Inc. is set to be sold for $27.00 per share in cash and Rocket Lab stock, while Theravance Biopharma, Inc. is priced at $17.00 per share, Synaptics Incorporated at 1.350 shares of onsemi stock per share, and Bio-Techne Corporation at $73.00 per share in cash.
- Shareholder Rights Protection: Halper Sadeh LLC encourages shareholders to contact the firm to discuss their rights and options at no cost, aiming to provide legal support and potential compensation for affected investors.
- Legal Service Commitment: The law firm commits to handling cases on a contingent fee basis, meaning shareholders will not be responsible for upfront legal fees or expenses, ensuring that more investors can access legal assistance.
See More
Chip Stocks Face Sell-Off, Investment Opportunities Emerge
- Market Sell-Off Impact: Chip stocks, particularly Nvidia, ON Semiconductor, and Intel, have faced significant declines this week due to increasing doubts about the returns on AI spending, putting pressure on the entire sector and requiring investors to navigate market volatility cautiously.
- Nvidia's Strong Performance: Despite an 18% drop from its 52-week high, Nvidia reported an 85% year-over-year revenue increase to $81.6 billion in Q1 2027, with data center revenue soaring 92% to $75.2 billion, highlighting its robust position in the AI market.
- ON Semiconductor Acquisition Risks: ON Semiconductor's stock plummeted 23% following its announcement of a $7 billion acquisition of Synaptics, raising concerns about shareholder dilution and integration risks, even as its Q1 revenue grew 5% year-over-year, which may impact its stock performance in the short term.
- Intel's Turnaround Challenges: Intel's stock has rebounded to around $128 from a 52-week low, with Q1 revenue up 7% to $13.6 billion, and securing Tesla as a major customer; however, it still faces profitability issues, making its turnaround uncertain and requiring investor vigilance.
See More
Chip Stocks Volatility and Investment Opportunities
- Nvidia Valuation Drop: Nvidia now trades at about 29 times earnings, significantly below its average over the past year, despite reporting an 85% year-over-year revenue increase to $81.6 billion in Q1 2027, with data center revenue soaring 92% to $75.2 billion, indicating strong performance in AI; however, market doubts about the sustainability of AI spending may lead to further stock volatility.
- ON Semiconductor Acquisition Risks: ON Semiconductor's announcement of a $7 billion all-stock acquisition of Synaptics triggered a more than 23% drop in its stock price in one day, although its Q1 revenue rose 5% year-over-year, signaling a recovery, the dilution effect of the acquisition and integration risks have unsettled investors, necessitating close monitoring of future performance.
- Intel Turnaround Success: Intel's stock has surged from a 52-week low of $19 to over $141, with Q1 revenue increasing 7% to $13.6 billion; however, despite reporting non-GAAP earnings of $0.29, its foundry business still lost $2.4 billion, indicating that the turnaround is not fully realized, and investors should remain cautious.
- Market Sentiment Impact: The entire chip sector has faced sell-offs due to concerns over AI spending, and while Nvidia, ON Semiconductor, and Intel each face unique challenges, this situation presents investors with opportunities to buy quality stocks at discounted prices, particularly as Nvidia maintains a competitive edge in a rapidly growing market.
See More
